Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer
2016 · Clinical Breast Cancer · 54 citations
https://doi.org/10.1016/j.clbc.2016.11.007
E
Enrique Bargalló‐Rocha
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
152
Papers
1.5K
Citations
22
h-index
46
i10-index
Enrique Bargalló‐Rocha is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & BRCA gene mutations in cancer & Global Cancer Incidence and Screening. The author has an h-index of 22, co-authored 130 publications.
ORCID: 0000-0003-2867-0332Papers by this author
worksConcurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
2009 · Radiation Oncology · 42 citations
https://doi.org/10.1186/1748-717x-4-24
Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population
2019 · BMC Cancer · 24 citations
https://doi.org/10.1186/s12885-019-5312-2
Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer
2018 · Cureus · 23 citations
https://doi.org/10.7759/cureus.3071
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment
2020 · Clinical Breast Cancer · 22 citations
https://doi.org/10.1016/j.clbc.2019.12.011
Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
2021 · Journal of Molecular Diagnostics · 20 citations
https://doi.org/10.1016/j.jmoldx.2021.07.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat